SEC Filing Summary for Bausch Health Companies Inc. (BHC)

Sarah B. Kavanagh, a director at Bausch Health Companies Inc. (BHC), acquired 45,871 shares of common stock on May 22, 2026, with a transaction price of $0.0. This acquisition is part of a restricted share unit (RSU) award granted to non-employee directors, valued at $250,000. The RSUs vest on the day before the next annual shareholder meeting and are settled in common shares. Following this transaction, Kavanagh directly owns 282,230 shares. The filing is Form 4, indicating a change in beneficial ownership.